Biomark Diagnostics Inc. (CSE:BUX)
0.3400
-0.0100 (-2.86%)
Oct 9, 2025, 3:58 PM EDT
Biomark Diagnostics Market Cap
Biomark Diagnostics has a market cap or net worth of CAD 33.56 million as of October 10, 2025. Its market cap has increased by 65.60% in one year.
Market Cap
33.56M
Enterprise Value
32.48M
Revenue
154.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
Market Cap Chart
Since November 27, 2014, Biomark Diagnostics's market cap has decreased from 40.39M to 33.56M, a decrease of -16.91%. That is a compound annual growth rate of -1.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 9, 2025 | 33.56M | 126.87% |
Dec 30, 2024 | 14.79M | -17.24% |
Dec 29, 2023 | 17.87M | 24.67% |
Dec 30, 2022 | 14.34M | -23.96% |
Dec 30, 2021 | 18.85M | 116.77% |
Dec 30, 2020 | 8.70M | -51.10% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 3.45B |
Green Thumb Industries | 2.93B |
Trulieve Cannabis | 2.37B |
dentalcorp Holdings | 2.17B |
Sienna Senior Living | 1.74B |
WELL Health Technologies | 1.42B |
Cronos Group | 1.39B |
Extendicare | 1.24B |